Literature DB >> 18923754

Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.

Ch Sampanis1.   

Abstract

Diabetes mellitus is recognized as a leading cause of chronic kidney disease and end-stage renal failure. Chronic renal failure is associated with insulin resistance and, in advanced renal failure, decreased insulin degradation. Both of these abnormalities are partially reversed with the institution of dialysis. Except for diet with protein restriction, patients with diabetes should be preferably treated with insulin. The management of the patients with hyperglycemia and chronic renal failure calls for close collaboration between the diabetologist and the nephrologists. This collaboration is very important so that the patient will not be confused and will not lose confidence to the doctors. Furthermore good glycemic control in these patients seems to reduce microvascular and macrovascular complications.

Entities:  

Keywords:  chronic kidney disease; diabetes; hyperglycemia therapy

Year:  2008        PMID: 18923754      PMCID: PMC2532962     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  58 in total

1.  Tests of glycemia in diabetes.

Authors:  David E Goldstein; Randie R Little; Rodney A Lorenz; John I Malone; David M Nathan; Charles M Peterson
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  Influence of erythropoietin treatment on glucose tolerance, insulin, glucagon, gastrin and pancreatic polypeptide secretion in haemodialyzed patients with end-stage renal failure.

Authors:  F Kokot; A Wiecek; W Grzeszczak; M Klin; E Zukowska-Szczechowska
Journal:  Contrib Nephrol       Date:  1990       Impact factor: 1.580

3.  Long-term glycemic control measurements in diabetic patients receiving hemodialysis.

Authors:  Melanie S Joy; William T Cefalu; Susan L Hogan; Patrick H Nachman
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 4.  Hydrolysis and transport of small peptides by the proximal tubule.

Authors:  F A Carone; D R Peterson
Journal:  Am J Physiol       Date:  1980-03

5.  Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia.

Authors:  R H Mak
Journal:  J Pediatr       Date:  1996-07       Impact factor: 4.406

6.  Similar risks of nephropathy in patients with type I or type II diabetes mellitus.

Authors:  C Hasslacher; E Ritz; P Wahl; C Michael
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

7.  Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure.

Authors:  T Inoue; N Shibahara; K Miyagawa; R Itahana; M Izumi; T Nakanishi; Y Takamitsu
Journal:  Clin Nephrol       Date:  2003-08       Impact factor: 0.975

8.  The relationship between glycemic control and morbidity and mortality for diabetics on dialysis.

Authors:  A H Tzamaloukas; G H Murata; P G Zager; B Eisenberg; P S Avasthi
Journal:  ASAIO J       Date:  1993 Oct-Dec       Impact factor: 2.872

9.  Splanchnic and renal metabolism of insulin in human subjects: a dose-response study.

Authors:  E Ferrannini; J Wahren; O K Faber; P Felig; C Binder; R A DeFronzo
Journal:  Am J Physiol       Date:  1983-06

Review 10.  Hypoglycemia associated with renal failure.

Authors:  R Arem
Journal:  Endocrinol Metab Clin North Am       Date:  1989-03       Impact factor: 4.741

View more
  7 in total

Review 1.  Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes.

Authors:  Olusola Olalekan Elekofehinti; Idowu Olaposi Omotuyi; Jean Paul Kamdem; Oluwamodupe Cecilia Ejelonu; Guimarae Vanessa Alves; Isaac Gbadura Adanlawo; João Batista Teixeira Rocha
Journal:  J Physiol Biochem       Date:  2014-02-25       Impact factor: 4.158

2.  In Silico Testing of an Artificial-Intelligence-Based Artificial Pancreas Designed for Use in the Intensive Care Unit Setting.

Authors:  Leon DeJournett; Jeremy DeJournett
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

3.  Renoprotective Roles of Curcumin.

Authors:  Habib Yaribeygi; Mina Maleki; Muhammed Majeed; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Dialysis-associated hyperglycemia: manifestations and treatment.

Authors:  Yijuan Sun; Maria-Eleni Roumelioti; Kavitha Ganta; Robert H Glew; James Gibb; Darlene Vigil; Catherine Do; Karen S Servilla; Brent Wagner; Jonathan Owen; Mark Rohrscheib; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2020-01-18       Impact factor: 2.370

Review 5.  Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.

Authors:  Carolina C R Betônico; Silvia M O Titan; Maria Lúcia C Correa-Giannella; Márcia Nery; Márcia Queiroz
Journal:  Clinics (Sao Paulo)       Date:  2016-01       Impact factor: 2.365

6.  Adult Nesidioblastosis in Chronic Kidney Disease.

Authors:  Eduardo Lozano-Melendez; Mercedes Aguilar-Soto; Luis Eugenio Graniel-Palafox; Laura Elena Ceceña-Martínez; Rafael Valdez-Ortiz; Fabio Solis-Jimenez
Journal:  Case Rep Endocrinol       Date:  2019-02-14

Review 7.  Management of anemia in patients with diabetic kidney disease: A consensus statement.

Authors:  Sarita Bajaj; Brij Mohan Makkar; Vinod K Abichandani; Pradeep G Talwalkar; Banshi Saboo; S S Srikanta; Ashok Das; Sruti Chandrasekaran; P Venkata Krishnan; Arun Shah; Georgi Abraham; Pankaj Tikku; Sushil Kumar
Journal:  Indian J Endocrinol Metab       Date:  2016 Mar-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.